期刊文献+

TRAIL、c-FLIP在大肠癌与转移淋巴结中的表达及意义 被引量:5

TRAIL and c-FLIP expression and significance in colorectal cancer and lymph node metastases
下载PDF
导出
摘要 目的检测TRAIL、c-FLIP在结直肠癌中的表达情况,探讨二者在大肠肿瘤的浸润转移及凋亡调控机制的可能相互关系和作用。方法选取新鲜结直肠癌、配对的癌旁正常组织各85例及转移淋巴结51例,运用Max Vision免疫组化和Western blot蛋白定量检测TRAIL、c-FLIP在各组间的表达,所得结果进行统计学分析。结果 (1)TRAIL在结直肠癌组织中的定位及表达位于细胞膜及细胞浆,而c-FLIP主要位于细胞浆。(2)TRAIL在癌组、转移淋巴结(LNM)组与癌旁正常组的均广泛表达,三者比较差异无统计学意义(P>0.05);癌组中,未/低分化阳性表达与中高分化比较、无LNM组与LNM组比较差异无统计学意义(P>0.05);(3)c-FLIP在癌组阳性表达明显高于正常组(且无一例强染色);转移淋巴结组阳性表达亦明显高于正常组,其强阳性表达88.2%(45/51),与癌组比较差异无统计学意义(P>0.05)。其癌组中未发生淋巴转移阳性表达88.2%(30/34)、淋巴转移100%(51/51)、未/低分化和中高分化分别为96.8%(30/31)、94.4%(51/54),81例阳性表达中强阳性74%(60/81);未/低分化腺癌与中高分化组表达比较差异无统计学意义(P>0.05)。(4)Western blot蛋白定量检测发现,对于TRAIL,呈现出c-FLIP蛋白表达越高,其表达也反应性增高的趋势,TRAIL蛋白的表达与c-FLIP的表达呈相互拮抗性正相关。结论 (1)c-FLIP在结直肠癌组织和转移淋巴结中存在过高表达,在正常组织低表达或不表达,而TRAIL在癌组织和转移淋巴结组织也存在相互拮抗性增高趋势。(2)高表达的c-FLIP可能与TRAIL死亡受体凋亡途径相互作用,对大肠癌的发生进展起到一定的作用。 Objective To investigate the TRAIL, C-Flip expression in colorectal cancer and infiltration transfer mechanism and explore their mutual relations and the role in colorectal tumor invasion and metastasis and apoptosis regulatory mechanism. Methods 85 cases of fresh colorectal cancer tissue specimens, paired adjacent normal colon rectal tissue specimens and 51 cases of metastatic lymph nodes were selected, TRAIL, C-Flip expression were detected by Max Vision immunohistochemistry and Western blot protein quantitative detection in each group, and the results were statistically analyzed. Results (1)The localization and expression of TRAIL in co]orectal carcinoma tissue were cell membrane and cytoplasm, while c-FLIP was mainly located in cytoplasm. (2)TRAIL was Widely expressed in cancer group, lymph node metastasis (LNM) group and adjacent normal group, but there was no significant difference in the three (P 〈 0.05). In carcinoma group, the positive expression rate of no/low differentiation group compared with medium/high differentiation group, and the positive expression rate of no LNM group compared with LNM group, difference were all not significant (P 〈 0.05). (3)positive expression rate of c-FLIP in cancer group was significantly higher than that in normal group (without strong staining); and expression rate of LNM group was obviously higher than that in normal group, the expression rate was 88.2% (45/51), compared with cancer group, the difference was not significant (P 〉 0.05). In cancer group, positive expression rate of no LNM group and LNM group were 88.2% ( 30/34 ) and 100% (51/51), expression rate of no/low differentiation group and medium/high differentiation group were 96.8% (30/31), 94.4% (51/54), the difference was not significant(P 〈 0.05). In 81 cases of positive expression, strong positive expression rate was 74% (60/81). (4)Western blot protein quantitative detection shows that TRAIL expression had a
出处 《中国医药科学》 2013年第12期10-13,共4页 China Medicine And Pharmacy
关键词 TRAIL C-FLIP 凋亡 结直肠癌 淋巴结转移 TRAIL c-FLIP Apoptosis Colorectal cancer Lymph node metastasis
  • 相关文献

参考文献4

二级参考文献49

  • 1Yu D, Hung MC. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies[J]. Oncogene, 2000, 19(53): 6115-6122.
  • 2Tsl M, King CR, Kraus MH, et al. Human HER2 (neu) promoter: Evidence for multiple mechanisms for transcriptional initiation[J]. Mol Cell Biol, 1987, 7(7): 2597-2601.
  • 3Scott GK, Chang CH, Emy KM, et al. Ets regulation of the erbB2promoter[ J ]. Oncogene, 2000, 19 (55): 6490-6502.
  • 4Scott GK, Daniel JC, Xiong X, et al. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells [ J ]. J Biol Chem, 1994,269(31): 19848-19858.
  • 5Hollywood DP, Hurst HC. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines[ J]. EMBO J, 1993, 12(6): 2369-2375.
  • 6Bosher JM, Williams T, Hurst HC. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma[J]. Proc Natl Aced Sci U S A, 1995,92(3): 744-747.
  • 7Grooteelaes M, Vemimmen D, Plaza S, et al. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells[J]. Cancer Res, 1999, 59(11): 2527-2531.
  • 8Raziuddin A, Court D, Sarkar FH, et al. A c-erbB-2 promoterspecific nuclear matrix protein from human breast tumor tissues mediates NF-kappaB DNA binding activity [J]. J Biol Chem, 1997,272(25): 15715-15720.
  • 9Dejardin E, Bonizzi G, Bellahcene A. Highly-expressed p100/p52(NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells [ J ]. Oncogene, 1995, 11 (9):183-189.
  • 10Chen Y, Fischer WH, Gill GN. Regulation of the ERBB-2 promoter by RBPJkappa and NOTCH[J]. J Biol Chem, 1997,272(22):14110-14114.

共引文献10

同被引文献62

  • 1顾宇平,束永前,张炜明,王聪.非小细胞肺癌中COX-2、VEGF和MVD的表达及其意义[J].苏州大学学报(医学版),2006,26(4):625-628. 被引量:12
  • 2Wang X,Chen W,Zeng W,et al.Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells[J].Mol Cancer Ther,2008,7 (5):1156-1163.
  • 3Yerbes R,López-Rivas A,Reginato MJ,et al.Controlof FLIP(L) expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells[J].Cell Death Differ,2012,19(12):1908-1916.
  • 4Jemal A, Tiwari RC, Murray T, et al.Cancer statistics [J]. CA Cancer J Clin, 2004,54 ( 1 ) : 8-29.
  • 5Fromowetz FB, Voila MV, Chao S, et al. Rasp21 expression in the progression of breast cancer[J].Human Patuol, 1987,18 ( 12 ) : 1268-1275.
  • 6Schindl M, Schoppmann SF, SamoniggH, et al. Overexpression of hypoxia -inducible factor 1 is associated with an unfavorable prognosis in lymph node-poditive reast cancer[J].Clin Cancer Inst, 2002,8 ( 7 ) : 1831-1837.
  • 7Landriscina M, Cassano A, Ratto C, et al.Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human coloreetalcancer[J].Br J Cancer, 1998:78 ( 6 ) : 765.
  • 8Oshida K, Nagashima T, et al.Pharmacokinetic analysis of ductal carcinoma in situ of the breast dynamic MR mammogramphy[J].Eur Radiol,2005,15 ( 7 ) : 1353- 1360.
  • 9Bono AV, Celato N, Cova V, et al.Microvessel density in prostate carcinoma[J].Prosate Cancer Prostatic Dis, 2002, 5 (2): 123-127.
  • 10Yamakawa M, Liu LX, Date T, et factor-1 mediat- es activeation al.Hypoxia-inducible of cultured vascular endotherlial cells by inducing multiple angiogenic[J]. Circulation Research, 2003,93 ( 7 ) : 664.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部